Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.30 -0.02 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Senti Biosciences Holdings (SNTI) EPS (Diluted) (2021 - 2026)

Analysis

Senti Biosciences Holdings (SNTI) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 1.79
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - -0.94
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn -0.11
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 0.42
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn -1.22
6 Beam Therapeutics 3.06 Bn 3.06 Bn - -1.18
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 0.05
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn -0.05
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 0.04
10 Senti Biosciences Holdings 10.28 Mn 10.28 Mn - -0.46
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.46
Dec 31, 2025 -0.82
Sep 30, 2025 -0.69
Jun 30, 2025 -0.56
Mar 31, 2025 -1.41
Dec 31, 2024 -3.47
Sep 30, 2024 -6.31
Jun 30, 2024 -2.45
Mar 31, 2024 -2.65
Dec 31, 2023 -4.12
Sep 30, 2023 -4.86
Jun 30, 2023 -4.26
Mar 31, 2023 -4.26
Dec 31, 2022 -9.27
Sep 30, 2022 -3.81
Jun 30, 2022 -16.17
Mar 31, 2022 -37.06
Dec 31, 2021 -13.24
Sep 30, 2021 -39.02
Jun 30, 2021 -30.92